Focused Ultrasound for Treatment of Movement Disorders: A Review of Non-Food and Drug Administration Approved Indications
Stereotactic and Functional Neurosurgery · 2024 · 102 (2) · 93-108
DOI: 10.1159/000535621 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Stereotactic and Functional Neurosurgery, online erschienen am 16.02.2024. Verfasst von Daniel D Cummins und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Mount Sinai Health System, New York, New York, USA. Hauptthemen laut MEDLINE: Dystonia, Essential Tremor, Parkinson Disease, Dyskinesias. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 54 Literaturangaben.
Abstract (Originalsprache)
Introduction
MRI-guided focused ultrasound (FUS) is an incisionless thermo-ablative procedure that may be used to treat medication-refractory movement disorders, with a growing number of potential anatomic targets and clinical applications. As of this article’s publication, the only US Food and Drug Administration (FDA)-approved uses of FUS for movement disorders are thalamotomy for essential tremor (ET) and tremor-dominant Parkinson’s Disease (PD), and pallidotomy for other cardinal symptoms of PD. We present a state-of-the-art review on all non-FDA approved indications of FUS for movement disorders, beyond the most well-described indications of ET and PD. Our objective was to summarize the safety and efficacy of FUS in this setting and provide a roadmap for future directions of FUS for movement disorders.
Methods
A state-of-the-art review was conducted on use of FUS for non-FDA approved movement disorders. All movement disorders excluding FDA-approved uses for ET and PD were included.
Results
A total of 25 studies on 172 patients were included. In patients with tremor plus dystonia syndromes (n = 6), ventralis intermediate nucleus of the thalamus (VIM)-FUS gave >50% tremor reduction, with no improvement in dystonia and worsened dystonia in 2/6 patients. Ventral-oralis complex (VO)-FUS gave >50% improvement for focal hand dystonia (n = 6) and 100% return to musical performance in musician’s dystonia (n = 6). In patients with multiple sclerosis (MS) and tremor (n = 3), improvement in tremor was seen in 2 patients with a favorable skull density ratio; no MS disease change was noted after VIM-FUS. In patients with tremor and comorbid ataxia syndromes (n = 3), none were found to have worsened ataxia after VIM-FUS; all had clinically significant tremor improvement. Subthalamic nucleus (STN)-FUS for PD (n = 49) gave approximately 50% improvement in PD motor symptoms, with dystonia and mild dyskinesias as possible adverse effects. Cerebellothalamic tract (CTT-FUS) for ET (n = 42) gave 55–90% tremor improvement, with gait dysfunction as a rare persistent adverse effect. Pallidothalamic tract (PTT-FUS) for PD (n = 50) gave approximately 50% improvement in motor symptoms, with mild speech dysfunction as a possible adverse effect.
Conclusion
VIM-FUS appeared safe and effective for heterogenous tremor etiologies, and VO-FUS appeared most effective for isolated segmental dystonia. STN-FUS was effective for PD symptom reduction; postoperative dystonia and mild on-medication dyskinesias required medical management. Tractography-based targeting with CTT-FUS for ET and PTT-FUS for PD demonstrated promising early results. Larger prospective trials with long-term follow-up are needed to the evaluate the safety and efficacy non-FDA approved indications for FUS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Mount Sinai Health System, New York, New York, USA.
- Department of Neurological Surgery, UCSF, San Francisco, California, USA.
Zitieren
APA
Cummins, D. D., Bernabei, J. M., & Wang, D. D. (2024). Focused Ultrasound for Treatment of Movement Disorders: A Review of Non-Food and Drug Administration Approved Indications. Stereotactic and Functional Neurosurgery, 102(2), 93-108. https://doi.org/10.1159/000535621
Vancouver
Cummins DD, Bernabei JM, Wang DD. Focused Ultrasound for Treatment of Movement Disorders: A Review of Non-Food and Drug Administration Approved Indications. Stereotactic and Functional Neurosurgery. 2024;102(2):93-108. doi:10.1159/000535621
BibTeX
@article{Cummins2024,
author = {Cummins, Daniel D and Bernabei, John M and Wang, Doris D},
title = {Focused Ultrasound for Treatment of Movement Disorders: A Review of Non-Food and Drug Administration Approved Indications},
journal = {Stereotactic and Functional Neurosurgery},
year = {2024},
volume = {102},
number = {2},
pages = {93--108},
doi = {10.1159/000535621}
}
EUVIMED